J. B. Chemicals & Pharmaceuticals Limited

NSEI:JBCHEPHARM 株式レポート

時価総額:₹278.0b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

J. B. Chemicals & Pharmaceuticals マネジメント

マネジメント 基準チェック /24

現在、CEO に関する十分な情報がありません。

主要情報

Nikhil Chopra

最高経営責任者

₹65.4m

報酬総額

CEO給与比率56.4%
CEO在任期間3.6yrs
CEOの所有権n/a
経営陣の平均在職期間1.5yrs
取締役会の平均在任期間3.8yrs

経営陣の近況

Recent updates

These 4 Measures Indicate That J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Using Debt Reasonably Well

Jun 28
These 4 Measures Indicate That J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Using Debt Reasonably Well

J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar

Apr 19
J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar

J. B. Chemicals & Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models

Feb 09
J. B. Chemicals & Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models

J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar

Dec 22
J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar

We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt

Nov 29
We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt

J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Dividend Will Be Increased To ₹9.25

Aug 03
J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Dividend Will Be Increased To ₹9.25

J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Due To Pay A Dividend Of ₹8.50

Feb 11
J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Due To Pay A Dividend Of ₹8.50

Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?

Dec 03
Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?

A Look At The Intrinsic Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

Sep 21
A Look At The Intrinsic Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly

Aug 03
J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly

Estimating The Fair Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

Jun 15
Estimating The Fair Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?

Mar 29
Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?

J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Has Re-Affirmed Its Dividend Of ₹8.50

Feb 16
J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Has Re-Affirmed Its Dividend Of ₹8.50

With EPS Growth And More, J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Interesting

Jan 27
With EPS Growth And More, J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Interesting

J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Could Easily Take On More Debt

Nov 30
J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Could Easily Take On More Debt

Here's Why I Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Might Deserve Your Attention Today

Sep 24
Here's Why I Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Might Deserve Your Attention Today

Are J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Investors Paying Above The Intrinsic Value?

Aug 03
Are J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Investors Paying Above The Intrinsic Value?

Do J. B. Chemicals & Pharmaceuticals's (NSE:JBCHEPHARM) Earnings Warrant Your Attention?

Jun 14
Do J. B. Chemicals & Pharmaceuticals's (NSE:JBCHEPHARM) Earnings Warrant Your Attention?

How Does J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Fare As A Dividend Stock?

May 04
How Does J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Fare As A Dividend Stock?

CEO報酬分析

J. B. Chemicals & Pharmaceuticals の収益と比較して、Nikhil Chopra の報酬はどのように変化したか?
日付総報酬給与会社業績
Mar 31 2024n/an/a

₹6b

Dec 31 2023n/an/a

₹5b

Sep 30 2023n/an/a

₹5b

Jun 30 2023n/an/a

₹4b

Mar 31 2023₹65m₹37m

₹4b

Dec 31 2022n/an/a

₹4b

Sep 30 2022n/an/a

₹4b

Jun 30 2022n/an/a

₹4b

Mar 31 2022₹59m₹18m

₹4b

Dec 31 2021n/an/a

₹4b

Sep 30 2021n/an/a

₹5b

Jun 30 2021n/an/a

₹4b

Mar 31 2021₹32m₹7m

₹4b

報酬と市場: Nikhilの 総報酬 ($USD 783.41K ) は、 Indian市場 ($USD 519.16K ) の同規模の企業の平均を上回っています。

報酬と収益: Nikhilの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Nikhil Chopra

3.6yrs

在職期間

₹65,448,000

報酬

Mr. Nikhil Ashokkumar Chopra serves as Chief Executive Officer and Whole-Time Director at J. B. Chemicals & Pharmaceuticals Limited since December 23, 2020 and has been its Director since May 10, 2020. He...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Nikhil Chopra
CEO & Whole-Time Director3.6yrs₹65.45mデータなし
Kunal Khanna
President of Operationsno data₹23.54mデータなし
Sridhar Bharadwaj
Vice President of HR & Administration8.5yrs₹11.55m0.00032%
₹ 889.7k
Himanshu Ranvah
Vice President of Legal1.4yrs₹1.63mデータなし
Pradeep Singh
President of Global Businessno data₹38.85m0.0039%
₹ 10.8m
Parmeshwar Bang
Executive Vice President of Operations of Damanless than a year₹15.54m0.0055%
₹ 15.2m
Bhushan Sachdeva
Executive Vice President of Supply Chain Operations1.5yrs₹17.60mデータなし
Jason D'Souza
Executive Vice Presidentless than a year₹14.33mデータなし
Dilip Rathore
President of India Businessno data₹23.86mデータなし
Sujay Rajhans
President of R&Dno data₹12.34mデータなし
Bharat Dhanani
Executive Vice President of Operations for Ankleshwar & Panoli1.5yrs₹15.86mデータなし
Vikrant Bendre
Assistant Vice Presidentno data₹11.09m0%
₹ 0

1.5yrs

平均在職期間

47yo

平均年齢

経験豊富な経営陣: JBCHEPHARMの経営陣は 経験豊富 とはみなされません ( 1.4年の平均在職年数)。これは新しいチームを示唆しています。


取締役

名称ポジション在職期間報酬所有権
Nikhil Chopra
CEO & Whole-Time Director3.8yrs₹65.45mデータなし
Shadrack Mapetla
Chairman of Biotech Laboratories (Pty ) Ltdno dataデータなしデータなし
Padmini Kaicker
Non-Executive & Independent Director3.9yrs₹7.50mデータなし
Prashant Kumar
Non-Executive Director3.9yrsデータなしデータなし
Akshay Tanna
Non-Executive & Non-Independent Directorless than a yearデータなしデータなし
Gaurav Trehan
Non-Executive Director3.4yrsデータなしデータなし
Sumit Bose
Non-Executive & Independent Director3.9yrs₹7.50mデータなし

3.8yrs

平均在職期間

64.5yo

平均年齢

経験豊富なボード: JBCHEPHARMの 取締役会経験豊富 であると考えられます ( 3.8年の平均在任期間)。